Clinical Trial Update: Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of NS2359 in adults with attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• NS2359

Snippet

Sponsor: NeuroSearch A/S | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED